You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 100 No. 9, September 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Toxicity of Intravitreous Miconazole

Felipe I. Tolentino, MD; C. Stephen Foster, MD; Moshe Lahav, MD; Luke H. S. Liu, MD; Arnold R. Rabin, MD

Arch Ophthalmol. 1982;100(9):1504-1509.


Abstract

• Miconazole nitrate is a broad-spectrum antimycotic agent with low systemic and ocular toxicity. Since this drug does not adequately penetrate the vitreous cavity by topical, subconjunctival, or intravenous routes, we determined whether it can be given intravitreously for fungal endophthalmitis. Retinal and lens toxicity studies were carried out in 40 rabbits and three owl monkeys. Results showed that both miconazole and its vehicle produced toxic damage to the retina and crystalline lens in concentrations of 100 µg or greater. Concentrations of 10 to 80 µg caused mild to moderate retinal necrosis in some rabbit eyes. In monkey eyes, these concentrations did not cause significant histopathologic or electroretinographic changes. We believe that clinical use of this drug in doses not to exceed 40 µg may be justified in desperate cases of fungal endophthalmitis.



Author Affiliations

From the Retina Associates (Dr Tolentino); the Eye Research Institute of Retina Foundation (Drs Tolentino, Foster, Lahav, and Liu); and the Massachusetts Eye and Ear Infirmary (Drs Tolentino, Foster, and Rabin), Boston. Dr Lahav is currently with the Department of Ophthalmology, Tufts-New England Medical Center, Boston.


Footnotes

Accepted for publication Oct 5, 1981.

This study was presented at the annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, Fla, May 5, 1980.

Reprint requests to Library, Eye Research Institute of Retina Foundation, 20 Staniford St, Boston, MA 02114 (Dr Tolentino).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.